Safety and Efficacy of Ruxolitinib in Patients With HNSCC and High NLR Treated With Pembrolizumab - The Phase 2 InflammaSTOP Trial
Safety and Efficacy of Ruxolitinib in Patients With HNSCC and High NLR Treated With Pembrolizumab - The Phase 2 InflammaSTOP Trial
Not yet recruiting · NCT07840456 · Registry updated 2026-09-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Ruxolitinib in Patients With HNSCC and High NLR Treated With Pembrolizumab - The Phase 2 InflammaSTOP Trial | Disease Attributes, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinoma | Not yet recruiting | Phase 2 | 2026-09-25 | NCT07840456 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Clinical Trial Unit, University Hospital Basel, Switzerland | 7 |
| University Hospital, Basel, Switzerland | 243 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Asklepios Klinik St. Georg Hamburg | Hamburg | Germany | 1 |
| Ente Ospedaliero Cantonale | Bellinzona | Switzerland | 2 |
| HOCH Health Ostschweiz | Sankt Gallen | Switzerland | 1 |
| Katholisches Krankenhaus Hagen | Hagen | Germany | 1 |
| Seeland Cancer Center Biel | Biel/Bienne | Switzerland | 1 |
| Uniklinik Köln | Cologne | Germany | 5 |
| University Hospital Basel | Basel | Switzerland | 14 |
| Universitätslklinikum Würzburg | Würzburg | Germany | 1 |
| Universitätsmedizin Greifswald | Greifswald | Germany | 4 |
| Universitätsspital Zürich | Zurich | Switzerland | 6 |